Table 3.
Changes of the CMS score and its components from the baseline to 48 weeks after intervention.
| Measure | Time | Group A (F-SWT) | Group B (R-SWT) | p value† |
|---|---|---|---|---|
| Total CMS score | Baseline | 66.7 ± 6.2 | 65.8 ± 4.7 | p > 0.05 |
| 4-week | 70.5 ± 4.3 | 70.3 ± 4.7 | p > 0.05 | |
| 12-week | 73.6 ± 6.0 | 71.2 ± 5.2 | p > 0.05 | |
| 24-week | 79.6 ± 5.6 | 75.0 ± 5.4 | p = 0.007 | |
| 48-week | 83.6 ± 6.0 | 76.8 ± 6.5 | p = 0.001 | |
|
| ||||
| Pain | Baseline | 7.7 ± 2.5 | 8.2 ± 2.5 | p > 0.05 |
| 4-week | 9.1 ± 2.5 | 9.3 ± 2.8 | p > 0.05 | |
| 12-week | 10.2 ± 2.4 | 10.0 ± 2.7 | p > 0.05 | |
| 24-week | 12.7 ± 2.5 | 10.7 ± 2.8 | p = 0.015 | |
| 48-week | 13.6 ± 2.3 | 11.6 ± 2.8 | p = 0.012 | |
|
| ||||
| ADL | Baseline | 14.2 ± 2.2 | 13.5 ± 2.3 | p > 0.05 |
| 4-week | 15.0 ± 1.8 | 14.1 ± 2.5 | p > 0.05 | |
| 12-week | 15.4 ± 2.1 | 14.4 ± 2.5 | p > 0.05 | |
| 24-week | 17.0 ± 2.0 | 14.7 ± 2.6 | p = 0.002 | |
| 48-week | 17.7 ± 1.9 | 16.0 ± 2.4 | p = 0.016 | |
|
| ||||
| ROM | Baseline | 30.3 ± 3.4 | 30.1 ± 3.2 | p > 0.05 |
| 4-week | 31.4 ± 3.0 | 32.5 ± 2.6 | p > 0.05 | |
| 12-week | 32.1 ± 3.1 | 32.8 ± 2.4 | p > 0.05 | |
| 24-week | 34.3 ± 2.2 | 33.9 ± 2.9 | p > 0.05 | |
| 48-week | 36.0 ± 3.0 | 34.1 ± 2.9 | p = 0.035 | |
|
| ||||
| Power | Baseline | 14.5 ± 4.0 | 14.0 ± 4.3 | p > 0.05 |
| 4-week | 15.1 ± 3.3 | 14.6 ± 3.5 | p > 0.05 | |
| 12-week | 15.9 ± 2.9 | 14.8 ± 3.8 | p > 0.05 | |
| 24-week | 15.9 ± 2.6 | 15.7 ± 3.3 | p > 0.05 | |
| 48-week | 16.3 ± 2.6 | 15.1 ± 3.1 | p > 0.05 | |
CMS: Constant and Murley Scale; ADL: activity of daily living; ROM: range of motion; F-SWT: focused shockwave therapy; R-SWT: radial shockwave therapy. †Unpaired t-test.